Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Apr 14, 2026
Why Is Credo Technology Group (CRDO) Stock Up +19% Today?

Why Is Credo Technology Group (CRDO) Stock Up +19% Today?

Key Takeaways

  • Shares of CRDO are surging approximately 19% in premarket trading on Tuesday, April 14, 2026, from a prior close of $134.36
  • The primary catalyst is Credo's announcement after Monday's close that it has entered into a definitive agreement to acquire DustPhotonics, a leading Israeli Silicon Photonics PIC developer, for $750 million in cash plus approximately 0.92 million shares of Credo common stock
  • The deal gives Credo full vertical integration across SerDes, DSP, Silicon Photonics, and system integration — a full-stack AI connectivity platform
  • Credo expects the combined optical portfolio to generate more than $500 million in optical revenue in fiscal 2027, with the deal expected to be accretive to non-GAAP EPS in the same year
  • Monday's regular session had already delivered a 12.35% gain on Jefferies' Buy initiation and elevated volume — the DustPhotonics announcement layered a fresh strategic catalyst on top of existing bullish momentum
  • Traders are watching the investor call scheduled for 10:00 a.m. Pacific Time on April 14 for details on deal financing, integration timeline, and revised revenue guidance

Opening Summary

Credo Technology Group Holding Ltd. (CRDO) is a San Jose-based semiconductor company specializing in high-speed, energy-efficient connectivity solutions for AI infrastructure, data centers, and hyperscale networks — most notably its Active Electrical Cable (AEC) and optical interconnect products. Shares are trading up approximately 19% in premarket on April 14, 2026, from a prior close of $134.36, implying a premarket price near $160, after the company disclosed a transformative acquisition of DustPhotonics following Monday's regular session close. The move extends a broader rally that already pushed CRDO up 12.35% during Monday's trading session, reflecting compounding bullish catalysts driving the stock to multi-week highs.

M&A Catalyst: DustPhotonics Acquisition

The centerpiece of Tuesday's premarket surge is Credo's definitive agreement to acquire DustPhotonics, an Israeli developer of Silicon Photonics Photonic Integrated Circuit (SiPho PIC) technology used in 400G, 800G, 1.6T, and 3.2T optical transceivers — with a technology roadmap extending to 3.2T Near Port Optics and Co-Packaged Optics applications. CRDO will pay $750 million in cash and approximately 0.92 million ordinary shares upfront, with up to approximately 3.21 million additional shares contingent on DustPhotonics achieving specific financial milestones. The total deal value has been characterized at approximately $1.2 billion when including the earnout component.

The strategic logic is compelling to investors: by bringing Silicon Photonics PIC technology in-house, Credo gains a vertically integrated connectivity stack spanning SerDes, Digital Signal Processing (DSP), Silicon Photonics, and full system integration — allowing the company to address both electrical and optical interconnects across the entire AI infrastructure build-out. Management projects the combined portfolio of ZeroFlap Optical Transceivers, Optical DSPs, and Silicon Photonics products to generate more than $500 million in optical revenue in fiscal 2027, representing a significant step-change in addressable market scale.

Prior Session Momentum and Analyst Catalyst

Monday's 12.35% regular-session gain for CRDO had already set a bullish tone heading into the DustPhotonics announcement. Jefferies initiated coverage on April 12 with a Buy rating and a $175 price target, arguing that investor concerns about optical substitution crowding out Credo's copper AEC business are overblown, and that the stock remains under-owned relative to its AI leverage. Trading volume on Monday reached approximately 9.76 million shares, roughly 39% above the stock's average volume, reflecting broad institutional interest before the acquisition news broke.

Additionally, CRDO had recently resolved all active electrical cable patent disputes with Molex and TE Connectivity through confidential license and cross-license settlements, removing a meaningful litigation overhang from the stock. With legal risk cleared, analyst coverage expanding bullishly, and now a major strategic acquisition, the conditions for an extended rally had been building systematically over recent sessions.

Market Context and Trading Activity

The premarket surge in CRDO is occurring against a backdrop of broader recovery in AI-related semiconductors, with S&P 500 futures also positive in Tuesday premarket. The DustPhotonics deal aligns thematically with the AI infrastructure buildout narrative that has benefited names across the optical and semiconductor connectivity space. Peers operating in silicon photonics and high-speed data center connectivity have been among the stronger performers in the technology sector in recent months.

From a technical standpoint, CRDO has been in a strong uptrend since late March, stair-stepping from near $87 on March 30 to above $134 by April 13 — a move of more than 50% in under three weeks. Monday's session demonstrated buyer conviction, with dips quickly absorbed and the stock consolidating near highs heading into the close. Tuesday's premarket gap higher extends the stock beyond recent intraday resistance levels, potentially opening new technical territory if the move is confirmed at the open.

Trending AI Robots

For traders looking to capitalize on momentum in names like CRDO, Tickeron's Trending AI Robots page offers a curated view of the platform's top-performing AI trading bots under current market conditions. Tickeron operates hundreds of automated bots covering thousands of tickers, each differentiated by strategy type, timeframe, risk tolerance, and performance metrics — but only those demonstrating the strongest results in the present market environment are featured in the Trending section. Bots span a wide range of approaches, from momentum and breakout strategies to mean-reversion and sector-rotation models, and performance data is displayed transparently for comparison. Traders seeking systematic, data-driven exposure to fast-moving markets may find the Trending AI Robots section a valuable starting point for exploring algorithmic trading options.

What Comes Next for CRDO

The immediate focus for CRDO will be the investor conference call on April 14 at 10:00 a.m. Pacific Time, where management is expected to detail deal financing, integration plans, and any updated revenue or margin outlook related to the DustPhotonics acquisition. The transaction is anticipated to close in the second quarter of calendar 2026, subject to customary regulatory approvals, and investors will be watching for any signals about how Credo plans to fund the $750 million cash component and whether additional capital raises are on the table.

Looking further ahead, Credo's next quarterly earnings report will provide the first opportunity to assess how the combined optical business is ramping toward the stated $500 million optical revenue target for fiscal 2027. Analyst consensus currently sits at a Buy, with average price targets well above current trading levels, though risk factors include customer concentration — with Microsoft and other hyperscalers driving the bulk of revenue — as well as execution risk in integrating DustPhotonics' Israeli operations and technology stack. The competitive landscape in silicon photonics remains intense, with well-capitalized rivals also targeting the high-speed optical transceiver market as AI data center capex continues to grow.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: CRDO

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


CRDO's RSI Oscillator ascends from oversold territory

The RSI Indicator for CRDO moved out of oversold territory on September 16, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In 27 of the 30 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 17, 2026. You may want to consider a long position or call options on CRDO as a result. In 57 of 66 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.

The Moving Average Convergence Divergence (MACD) for CRDO just turned positive on September 21, 2026. Looking at past instances where CRDO's MACD turned positive, the stock continued to rise in 37 of 44 cases over the following month. The odds of a continued upward trend are 84%.

CRDO moved above its 50-day moving average on October 01, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +12.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRDO advanced for three days, in 284 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The 10-day moving average for CRDO crossed bearishly below the 50-day moving average on August 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRDO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

CRDO broke above its upper Bollinger Band on September 25, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CRDO entered a downward trend on September 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. CRDO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.280) is normal, around the industry mean (7.902). P/E Ratio (67.842) is within average values for comparable stocks, (163.223). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.705). Dividend Yield (0.000) settles around the average of (0.007) among similar stocks. P/S Ratio (19.342) is also within normal values, averaging (45.163).

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRDO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock worse than average.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), QUALCOMM (NASDAQ:QCOM), Analog Devices (NASDAQ:ADI).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 216.18B. The market cap for tickers in the group ranges from 86.8K to 5.53T. NVDA holds the highest valuation in this group at 5.53T. The lowest valued company is STRB at 86.8K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 5%. For the same Industry, the average monthly price growth was 12%, and the average quarterly price growth was 51%. WOLF experienced the highest price growth at 22%, while MOBX experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was 5%. For the same stocks of the Industry, the average monthly volume growth was -0% and the average quarterly volume growth was -57%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 51
Price Growth Rating: 41
SMR Rating: 72
Profit Risk Rating: 71
Seasonality Score: 20 (-100 ... +100)
View a ticker or compare two or three
CRDO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Semiconductors

Industry
N/A
Address
c/o Maples Corporate Services
Phone
N/A
Employees
807
Web
https://www.credosemi.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
Why Is Credo Technology Group (CRDO) Stock Up +19% Today?